DrugPatentWatch Database Preview
CENTANY Drug Patent Profile
Email this page to a colleague
When do Centany patents expire, and when can generic versions of Centany launch?
Centany is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in CENTANY is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Centany
A generic version of CENTANY was approved as mupirocin by PADAGIS ISRAEL on November 7th, 2003.
Summary for CENTANY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 2 |
| Patent Applications: | 6,137 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CENTANY |
| What excipients (inactive ingredients) are in CENTANY? | CENTANY excipients list |
| DailyMed Link: | CENTANY at DailyMed |
Recent Clinical Trials for CENTANY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Texas Southwestern Medical Center | Phase 2 |
| National Jewish Health | Phase 2 |
| University of North Carolina, Chapel Hill | Phase 2 |
Pharmacology for CENTANY
| Drug Class | RNA Synthetase Inhibitor Antibacterial |
| Mechanism of Action | RNA Synthetase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for CENTANY
US Patents and Regulatory Information for CENTANY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | BX | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CENTANY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | ⤷ Try it Free | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CENTANY
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2259764 | ⤷ Try it Free |
| Spain | 2165723 | ⤷ Try it Free |
| Israel | 123143 | ⤷ Try it Free |
| European Patent Office | 0933081 | ⤷ Try it Free |
| Germany | 69900561 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
